NO170216C - Analogifremgangsmaate for fremstilling av antihypertensiveog antiarytmiske kromanolderivater - Google Patents

Analogifremgangsmaate for fremstilling av antihypertensiveog antiarytmiske kromanolderivater

Info

Publication number
NO170216C
NO170216C NO882762A NO882762A NO170216C NO 170216 C NO170216 C NO 170216C NO 882762 A NO882762 A NO 882762A NO 882762 A NO882762 A NO 882762A NO 170216 C NO170216 C NO 170216C
Authority
NO
Norway
Prior art keywords
chromanold
antiarithmic
antihypertensive
derivatives
preparation
Prior art date
Application number
NO882762A
Other languages
English (en)
Norwegian (no)
Other versions
NO170216B (no
NO882762D0 (no
NO882762L (no
Inventor
Georges Garcia
Richard Roux
Dino Nisato
Patrick Gautier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8708830A external-priority patent/FR2617165B1/fr
Priority claimed from FR8800278A external-priority patent/FR2625744B1/fr
Priority claimed from FR8803064A external-priority patent/FR2628424B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO882762D0 publication Critical patent/NO882762D0/no
Publication of NO882762L publication Critical patent/NO882762L/no
Publication of NO170216B publication Critical patent/NO170216B/no
Publication of NO170216C publication Critical patent/NO170216C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
    • C10L1/00—Liquid carbonaceous fuels
    • C10L1/32—Liquid carbonaceous fuels consisting of coal-oil suspensions or aqueous emulsions or oil emulsions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO882762A 1987-06-23 1988-06-22 Analogifremgangsmaate for fremstilling av antihypertensiveog antiarytmiske kromanolderivater NO170216C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8708830A FR2617165B1 (fr) 1987-06-23 1987-06-23 Derives du dimethyl-2, 2 chromannol-3
FR8800278A FR2625744B1 (fr) 1988-01-12 1988-01-12 Derives du dimethyl-2,2 chromannol-3 procede d'obtention et compositions pharmaceutiques en contenant
FR8803064A FR2628424B1 (fr) 1988-03-09 1988-03-09 Derives du dimethyl-2,2 chromannol-3 procede d'obtention et compositions pharmaceutiques en contenant

Publications (4)

Publication Number Publication Date
NO882762D0 NO882762D0 (no) 1988-06-22
NO882762L NO882762L (no) 1988-12-27
NO170216B NO170216B (no) 1992-06-15
NO170216C true NO170216C (no) 1992-09-23

Family

ID=27251476

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882762A NO170216C (no) 1987-06-23 1988-06-22 Analogifremgangsmaate for fremstilling av antihypertensiveog antiarytmiske kromanolderivater

Country Status (9)

Country Link
EP (1) EP0296975A1 (sv)
JP (1) JPS6426578A (sv)
KR (1) KR890000470A (sv)
DK (1) DK343388A (sv)
FI (1) FI90343C (sv)
IL (1) IL86798A (sv)
NO (1) NO170216C (sv)
NZ (1) NZ225117A (sv)
PT (1) PT87788B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US5284838A (en) * 1987-06-23 1994-02-08 Elf Sanofi Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use
US5254557A (en) * 1988-05-09 1993-10-19 Beecham Group P.L.C. Compound and treatment
EP0373204A1 (en) * 1988-05-09 1990-06-20 Beecham Group Plc Novel compounds and treatment
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
ES2071668T3 (es) * 1988-12-13 1995-07-01 Beecham Group Plc Benzopirano y compuestos relacionados.
GB8902118D0 (en) * 1989-02-01 1989-03-22 Beecham Group Plc Chemical process
US5239090A (en) * 1989-02-01 1993-08-24 Beecham Group P.L.C. Certain optically active 3,4-dihydrobenzopyran-4-ols which are intermediates
US5066816A (en) * 1989-03-03 1991-11-19 Yoshitomi Pharmaceutical Industries, Ltd. Processes for preparing optically active 3,4-dihydro-3,4-epoxy-2h-1-benzopyran compounds and intermediates therefor
US5162553A (en) * 1989-03-03 1992-11-10 Yoshitomi Pharmaceutical Industries, Ltd. Processes for preparing optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compounds and intermediates therefor
FR2645021A1 (fr) * 1989-03-30 1990-10-05 Sanofi Sa Utilisation d'un agoniste potassique dans le traitement du glaucome
DE3923839A1 (de) * 1989-07-19 1991-01-31 Beiersdorf Ag Benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
GB8916683D0 (en) * 1989-07-21 1989-09-06 Beecham Group Plc Novel compounds
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
DE3926001A1 (de) * 1989-08-05 1991-02-07 Merck Patent Gmbh Chromanderivate
FR2657872B2 (fr) * 1989-11-06 1992-06-12 Sanofi Sa Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
FR2654103B1 (fr) * 1989-11-06 1992-02-21 Sanofi Sa Derives d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques les contenant.
US5185345A (en) * 1989-11-06 1993-02-09 Sanofi 4-amidino pyrano (3,2-c) pyridine derivatives, and pharmaceutical compositions containing them
DE4115465A1 (de) * 1991-05-11 1992-11-12 Beiersdorf Ag Neue in 4-stellung durch aryl oder n-heteroaryl substituierte 2h-benzo(b)pyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
BR9206845A (pt) * 1991-12-05 1996-01-02 Smithkline Beecham Plc Composto famacêutico
GB9203596D0 (en) * 1992-02-20 1992-04-08 Smithkline Beecham Plc Novel process
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
ES2145129T3 (es) * 1992-08-17 2000-07-01 Chugai Pharmaceutical Co Ltd Derivados de benzopirano y benzoxazina.
US6031115A (en) * 1993-05-14 2000-02-29 Smithkline Beecham Plc Process for preparing epoxides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE23718T1 (de) * 1981-09-25 1986-12-15 Beecham Group Plc Benzopyran-verbindungen mit pharmazeutischer wirkung.
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
DE3579390D1 (de) * 1984-06-22 1990-10-04 Beecham Group Plc Wirksame benzopyranverbindungen.
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate

Also Published As

Publication number Publication date
FI90343B (sv) 1993-10-15
DK343388A (da) 1988-12-24
FI90343C (sv) 1994-01-25
DK343388D0 (da) 1988-06-22
NO170216B (no) 1992-06-15
FI882945A (sv) 1988-12-24
PT87788A (pt) 1988-07-01
EP0296975A1 (fr) 1988-12-28
NZ225117A (en) 1990-02-26
KR890000470A (ko) 1989-03-14
NO882762D0 (no) 1988-06-22
IL86798A0 (en) 1988-11-30
IL86798A (en) 1992-12-01
PT87788B (pt) 1992-10-30
FI882945A0 (sv) 1988-06-20
NO882762L (no) 1988-12-27
JPS6426578A (en) 1989-01-27

Similar Documents

Publication Publication Date Title
NO170216C (no) Analogifremgangsmaate for fremstilling av antihypertensiveog antiarytmiske kromanolderivater
NO171979C (no) Analogifremgangsmaate for fremstilling av antibakterielle kinolon- og naftyridinderivater
NO161370C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridin-derivater.
NO862650L (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO166854C (no) Analogifremgangsmaate til fremstilling av tetrahydronaftalin- og indanderivater.
NO170483C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrahydronaftalin- og indanderivater
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO169014C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive distamycinderivater
NO912344L (no) Fremgangsmaate for fremstilling av benzopyranderivater og heterocykliske derivater derav
NO162721C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridinderivater.
NO172849C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater
NO168826C (no) Analogifremgangsmaate for fremstilling av poly-4-aminopyrrol-2-karboksamidoderivater
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO173604C (no) Analogifremgangsmaate til fremstilling av bis-dioksopiperazinderivater
NO872463D0 (no) Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning.
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO880294D0 (no) Fremgangsmaate for fremstilling av tetrahydrofuranderivater
NO170418C (no) Analogifremgangsmaate ved fremstilling av pyrrolokinolin- og pyrrolofenotiazinkarboksamider
NO845148L (no) Fremgangsmaate for fremstilling av 16-fenoksy- og 16-substituert-fenoksy-prostatrinsyre-derivater
NO891985D0 (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
NO904805D0 (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske pyridinderivater.
NO863113D0 (no) Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner.
NO882335D0 (no) Fremgangsmaate for fremstilling av 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener.
NO863434L (no) Fremgangsmaate for fremstilling av metylendioksyfenantren- og stilbenderivater.